New frontiers in endocrinology of eating disorders

Current Topics in Behavioral Neurosciences

Volumn 6, Issue 1, 2011, Pages 189-208

  Monteleone, Palmiero ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Anorexia nervosa; Bulimia nervosa; Eating disorders; Feeding regulators; Motivated behaviors; Neuroendocrinology; Reward

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID; DRONABINOL; ENDOCANNABINOID; GHRELIN; NABILONE; OBESTATIN; OPIATE PEPTIDE; PLACEBO; ULIMORELIN; NARCOTIC ANALGESIC AGENT;

ANOREXIA; ANOREXIA NERVOSA; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; BULIMIA; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EATING DISORDER; ENDOCRINOLOGY; FOOD INTAKE; GENE; GENE FREQUENCY; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; UNSPECIFIED SIDE EFFECT; WASTING SYNDROME; ANIMAL; METABOLISM; PSYCHOLOGICAL ASPECT; REVIEW;

ANALGESICS, OPIOID; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; EATING DISORDERS; ENDOCANNABINOIDS; ENDOCRINOLOGY; GHRELIN; HUMANS; REWARD;

EID: 80555133607     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2010_87     Document Type: Article

References (112)

1. Arosio M, Ronchi CL, Beck-Peccoz P et al (2004) Effects of modified sham feeding on ghrelin levels in healthy human subjects. J Clin Endocrinol Metab 89:5101-5104.
2. Asakawa A, Inui A, Fujimiya M et al (2005) Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54:18-24.
3. Baranowska B (1990) Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa. Psychoneuroendocrinology 15:371-379.
4. Beriohay B, Lebrun B, Moyse E et al (2005) Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology 146:5612-5620.
5. Berridge KC (1997) Brain reward systems for food incentives hedonics in normal appetite and eating disorders. In: Kirkham TC, Cooper SJ (eds) Appetite and body weight: integrative systems and the development of anti-obesity drugs. Academic Press, Burlington
6. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309-369.
7. Berry EM (2006) Pilot study of THC (2.5 mg x 2) in 9 ambulatory AN patients (abstract). In: The sixth nordic congress on eating disorders, Aarhus, Denmark
8. Brambilla F, Ferrari E, Petraglia F et al (1991) Peripheral opioid secretory pattern in anorexia nervosa. Psychiatry Res 39:115-127.
9. Brambilla F, Monteleone P, Maj M (2008) Central and peripheral peptide regulation of hunger, satiety and food intake in eating disorders. In: Czerbska MT (ed) Psychoneuroendocrinology research trends. Nova Biomedical Books, New York
10. Brewerton TD, Lydiard RB, Laraia MT et al (1992) CSF-b-endorphin and dynorphin in bulimia nervosa. Am J Psychiatry 149:1086-1090.
11. Broglio F, Gianotti L, Destefanis S et al (2004) The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf) 60:592-599.
12. Chen CY, Inui A, Asakawa A et al (2005) Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129:8-25.
13. Cota D, Marsicano G, Tschop M et al (2003a) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423-431.
14. Cota D, Marsicano G, Lutz B et al (2003b) Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 27:289-301.
15. Cummings DE, Purnell JQ, Frayo RS et al (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719.
16. Di Marzo V, Goparaju SK, Wang L et al (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-825.
17. Diano S, Farr SA, Benoit SC et al (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9:381-388.
18. Ehrlich S, Salbach-Andrae H, Eckart S et al (2009) Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa. J Psychiatry Neurosci 34(4):323-329.
19. Fladung AK, Grön G, Grammer K et al (2010) A neural signature of anorexia nervosa in the ventral striatal reward system. Am J Psychiatry 167(2):206-212.
20. Fraser GL, Hoveyda HR, Tannenbaum GS (2008) Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist. Endocrinology 149:6280-6288.
21. Friederich HC, Kumari V, Uher R et al (2006) Differential motivational responses to food and pleasurable cues in anorexia and bulimia nervosa: a startle reflex paradigm. Psychol Med 36:1327-1335.
22. Fullerton DT, Swift WJ, Getto CJ et al (1986) Plasma immunoreactive beta-endorphin in bulimics. Psychol Med 16:56-63.
23. Galderisi S, Mucci A, Monteleone P et al (2003) Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids. Biol Psychiatry 53:921-927.
24. Garg A (2007) Commentary: the ongoing saga of obestatin: is it a hormone? J Clin Endocrinol Metab 92:3396-3398.
25. Gelegen C, van den Heuvel J, Collier DA et al (2008) Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. Genes Brain Behav 7:552-559.
26. Gerner RH, Sharp S (1982) B-endorphin immunoreactivity in normal, schizophrenic, depressed, manic, and anorexic subjects. Brain Res 237:244-247.
27. Gourcerol G, St-Pierre DH, Taché Y (2007) Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept 141:1-7.
28. Gross H, Ebert MH, Faden VB et al (1983) A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa before and during weight recovery. J Clin Psychopharmacol 3:165-171.
29. Hanada T, Toshinai K, Kajimura N et al (2003) Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 301:275-279.
30. Haney M, Rabkin J, Gunderson E et al (2005) Dronabinol and marijuana in HIV+mar ijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) 181:170-178.
31. Harada T, Nakahara T, Yasuhara D et al (2008) Obestatin, acylghrelin, and des-acylghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry 63:245-247.
32. Hotta M, Ohwada R, Katakami H et al (2004) Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab 89:5707-5712.
33. Hotta M, Ohwada R, Akamizu T et al (2009) Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a Pilot Study. Endocr J 56:1119-1128.
34. Janas-Kozik M, Krupka-Matuszczyk I, Malinowska-Kolodziej I et al (2007) Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa. Regul Pept 140:43-46.
35. Jerlhag E, Egecioglu E, Dickson SL et al (2007) Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbes. Addict Biol 12:6-16.
36. Kaye WH (1996) Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res 62:65-74.
37. Kaye WH (2008) Neurobiology of anorexia and bulimia nervosa. Physiol Behav 94:121-135.
38. Kaye WH, Pickar D, Naber D et al (1982) Cerebrospinal fluid opioid activity in anorexia nervosa. Am J Psychiatry 139:643-645.
39. Kaye WH, Berrettini WH, Gwirtsman HE et al (1987) Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including b-endorphin) in anorexia nervosa. Life Sci 41:2147-2155.
40. Kaye WH, Fudge JL, Paulus M (2009) New insight into symptoms and neurocircuit function of anorexia nervosa. Nature Rev Neurosci 10:573-584.
41. Kelley AE, Balski VP, Haber SN et al (2002) Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76:365-377.
42. Kernie SG, Liebl DJ, Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290-1300.
43. Kirkham TC, Williams CM, Fezza F et al (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550-557.
44. Kissileff HR, Wentzlaff TH, Guss JL et al (1996) A direct measure of satiety disturbance in patients with bulimia nervosa. Physiol Behav 60:1077-1085.
45. Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660.
46. Kojima S, Nakahara T, Nagai N et al (2005) Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin Endocrinol (Oxf) 62:74-78.
47. Lasègue C (1873) De l'anorexie hystèrique. Arch Gèn Mèd 1:384-403.
48. Lesem MD, Berrettini WH, Kaye WH et al (1991) Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia. Biol Psychiatry 29:244-252.
49. Lewin GR, Barde YA (1996) Physiology of neurotrophins. Annu Rev Neurosci 19:289-317.
50. Lyons WE, Mamounas LA, Ricaurte GA et al (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96:15239-15244.
51. Malik S, McGlone F, Bedrossian D et al (2008) Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 7:400-409.
52. Mercader JM, RibasèsM, Gratacòs M et al (2007) Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav 6:706-716.
53. Miljic D, Pekic S, Djurovic M et al (2006) Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 91:1491-1495.
54. Misra M, Miller K, Herzog D et al (2004) Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 89:1605-1612.
55. Misra M, Miller KK, Stewart V (2005) Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 90:5082-5087.
56. Monteleone P, Martiadis V, Fabrazzo M. et al (2003) Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol Med 33:1387-1394.
57. Monteleone P, Tortorella A, Martiadis V et al (2004) Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 66:744-748.
58. Monteleone P, Fabrazzo M, Tortorella A et al (2005a) Circulating ghrelin is decreased in nonobese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology 30:243-250.
59. Monteleone P, Martiadis V, Rigamonti AE et al (2005b) Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol Psychiatry 57:926-931.
60. Monteleone P, Fabrazzo M, Martiadis V et al (2005c) Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables. Psychol Med 35:897-905.
61. Monteleone P, Matias I, Martiadis V et al (2005d) Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30:1216-1221.
62. Monteleone P, Castaldo E, Maj M (2008a) Neuroendocrine dysregulation of food intake in eating disorders. Regul Pept 149:39-50.
63. Monteleone P, Serritella C, Martiadis V et al (2008b) Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biol Psychiatry 64:1005-1008.
64. Monteleone P, Serritella C, Martiadis V et al (2008c) Plasma obestatin, ghrelin, and ghrelin/ obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J Clin Endocrinol Metab 93:4418-4421.
65. Monteleone P, Bifulco M, Di Filippo C et al (2009) Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. Genes Brain Behav 8:728-732.
66. Monteleone P, Serritella C, Scognamiglio P et al (2010) Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa. Psychoneuroendocrinology 35:284-288. doi:10.1016/j.psyneuen.2009.07.001.
67. Morley JE, Blundell JE (1988) The neurobiological basis of eating disorders: some formulations. Biol Psychiatry 23:53-78.
68. Muller TD, Reichwald K, Bronner G et al (2008) Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adolesc Psychiatry Ment Health 2:33-39.
69. Murphy KG, Bloom SR (2006) Gut hormones and the regulation of energy homeostasis. Nature 444:854-859.
70. Nagaya N, Moriya J, Yasumura Y et al (2004) Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110:3674-3679.
71. Nagaya N, Itoh T, Murakami S et al (2005) Treatment of cachexia with ghrelin in patients with COPD. Chest 128:1187-1193.
72. Nakagawa T, Tsuchida A, Itakura Y et al (2000) Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 49:436-444.
73. Nakagawa T, Ogawa Y, Ebihara K et al (2003) Anti-obesity and anti-diabetic effects of brainderived neurotrophic factor in rodent models of leptin resistance. Int J Obes Relat Metab Disord 27:557-565.
74. Nakahara T, Harada T, Yasuhara D et al (2008) Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 64:252-255.
75. Nakai Y, Hosoda H, Nin K et al (2003) Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur J Endocrinol 149:R1-R3.
76. Nakazato M, Hashimoto K, Shimizu E (2003) Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54:485-490.
77. Nakazato M, Hashimoto K, Shiina A (2004) No changes in serum ghrelin levels in female patients with bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 28:1181-1184.
78. Nakazato M, Hashimoto K, Yoshimura K (2006) No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery. Prog Neuropsychopharmacol Biol Psychiatry 30:1117-1121.
79. Neary NM, Small CJ, Wren AM et al (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832-2836.
80. Nedvidkova J, Krykorkova I, Bartak V (2003) Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 88:1678-1682.
81. Otto B, Cuntz U, Fruehauf E (2001) Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145:R5-R9.
82. Otto B, Tschop M, Cuntz U (2004) Similar fasting ghrelin levels in binge eating/purging anorexia nervosa and restrictive anorexia nervosa. Psychoneuroendocrinology 29:692-693.
83. Otto B, Tschop M, Fruhauf E et al (2005) Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 30:577-581.
84. Owen WP, Halmi KA, Gibbs J et al (1985) Satiety responses in eating disorders. J Psychiatr Res 19:279-284.
85. Pearce JM (2004) Richard Morton: origins of anorexia nervosa. Eur Neurol 52:191-192.
86. Pelleymounter MA, Cullen MJ, Wellman CL (1995) Characteristics of BDNF-induced weight loss. Exp Neurol 131:229-238.
87. Prince AC, Brooks SJ, Stahl D et al (2009) Systematic review and meta-analysis of the baseline concentrations and physiological responses of gut hormones to food in eating disorders. Am J Clin Nutr 89:755-765.
88. Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593-1599.
89. Schwartz MW, Woods SC, Porte D Jr et al (2000) Central nervous system control of food intake. Nature 404:661-671.
90. Seoane LM, Al-Massadi O, Pazos Y et al (2006) Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29:RC13-RC15.
91. Simonian HP, Kresge KM, Boden GH et al (2005) Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol Motil 17:348-354.
92. Solinas M, Justinova Z, Goldberg SR et al (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nuclear accumbens shell in rats. J Neurochem 98:408-419.
93. Soriano-Guillen L, Barrios V, Campos-Barros A et al (2004) Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 144:36-42.
94. Stock S, Leichner P, Wong AC (2005) Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90:2161-2168.
95. Støving RK, Andries A, Brixen K et al (2009) Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa. J Psychiatr Res 43:671-679. doi:10.1016/j.jpsy chires.2008.09.007.
96. Tanaka M, Naruo T, Muranaga T (2002) Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 146:1-3.
97. Tanaka M, Naruo T, Yasuhara D (2003a) Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology 28:829-835.
98. Tanaka M, Narau T, Nagai N et al (2003b) Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. J Psychiatr Res 37:17-22.
99. Tanaka M, Tatebe Y, Nakahara T et al (2003c) Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa. Clin Endocrinol (Oxf) 59:574-579.
100. Tanaka M, Nakahara T, Kojima S et al (2004) Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa. Regul Pept 122:163-168.
101. Tepper R, Weixman A, Apter A et al (1992) Elevated plasma immunoreactive b-endorphin in anorexia nervosa. Clin Neuropharmacol 15:387-391.
102. Troisi A, Di Lorenzo G, Lega I et al (2005) Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 81:259-266.
103. Tsuchida A, Nonomura T, Ono-Kishino M (2001) Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes Relat Metab Disord 25:1286-1293.
104. Uehara T, Omori I, Nakamura K et al (2005) Plasma des-acyl and acyl ghrelin in patients with eating disorders. Eat Weight Disord 10:264-266.
105. Volicer L, Stelly M, Morris J et al (1997) Effects of dronabinol on anorexia and disturbed behaviour in patients with Alzheimer's disease. Int J Geriatr Psychiatry 12:910-919.
106. Wagner A, Aizenstein H, Venkatraman VK et al (2007) Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 164:1842-1849.
107. Waller DA, Kiser RS, Hardy BW et al (1986) Eating behavior and plasma beta-endorphin in bulimia. Am J Clin Nutr 44:20-23.
108. Will MJ, Franzblau EB, Kelley AE (2003) Nucleus accumbens m-opioids regulate intake of high-fat diet via activation of a distributed brain network. J Neurosci 23:2882-2888.
109. Williams CM, Kirkham TC (2002) Observational analysis of feeding induced by Delta-9-THC and anandamide. Physiol Behav 76:241-250.
110. Xu B, Goulding EH, Zang K et al (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736-742.
111. Zhang JV, Ren PG, Avsian-Kretchmer O et al (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-999.
112. Zhu X, Cao Y, Voogd K et al (2006) On the processing of proghrelin to ghrelin. J Biol Chem 281:38867-38870